Reckitt Benckiser Group PLC

Reckitt Benckiser Group PLC extends its powerhouse Mucinex OTC cough/cold brand into the saline nasal spray market with a dual-nozzle technology giving users the option of normal or higher-pressure s

Abbott continues rebounding from infant formula production problems and widespread recalls in 2022 while also facing lawsuits targeting those products in addition to multi-district litigation allegi

Potential regulatory action to remove oral phenylephrine-containing drugs from the US market would be slow, but lawsuits alleging harm to consumers already are being filed following an expert advisory

A competitor’s challenge to Abbott ’s “#1 infant formula brand” label claim for Similac infant formula products was resolved much faster as well as more simply than Abbott’s problems linked to bacter